Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
leish-111f + mpl-se (1 trial)
Leishmaniasis (Phase 1)
Leishmaniasis, Cutaneous (Phase 1)
Trials (1 total)
Trial APIs (1 total)